ATC Group: N01AX Other general anesthetics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01AX in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01A Anesthetics, general
4 N01AX Other general anesthetics

Group N01AX contents

Code Title
N01AX03 Ketamine
N01AX04 Propanidid
N01AX05 Alfaxalone
N01AX07 Etomidate
N01AX10 Propofol
N01AX11 Hydroxybutyric acid
N01AX13 Nitrous oxide
N01AX14 Esketamine
N01AX15 Xenon
N01AX63 Nitrous oxide, combinations

Active ingredients in N01AX

Active Ingredient

Esketamine is the S-enantiomer of racemic ketamine. It is a non-selective, non-competitive, antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. Through NMDA receptor antagonism, esketamine produces a transient increase in glutamate release leading to increases in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) stimulation and subsequently to increases in neurotrophic signalling which may contribute to the restoration of synaptic function in these brain regions involved with the regulation of mood and emotional behaviour. Restoration of dopaminergic neurotransmission in brain regions involved in the reward and motivation, and decreased stimulation of brain regions involved in anhedonia, may contribute to the rapid response.

Etomidate is an imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization.

Ketamine is a rapidly acting general anaesthetic for intravenous or intramuscular use with a distinct pharmacological action. Ketamine hydrochloride produces dissociative anaesthesia characterised by catalepsy, amnesia, and marked analgesia which may persist into the recovery period.

Nitrous oxide is a potent analgesic and a weak anaesthetic. Induction with nitrous oxide is relatively rapid, but a concentration of about 70% is needed to produce unconsciousness.

Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds.

Sodium oxybate is a central nervous system depressant which reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy and modifies sleep architecture reducing fragmented nighttime sleep. The precise mechanism by which sodium oxybate produces an effect is unknown, however sodium oxybate is thought to act by promoting slow (delta) wave sleep and consolidating night-time sleep.

Related product monographs

Document Type Information Source  
 DIPRIVAN Emulsion for injection or infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 HYPNOMIDATE Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 KETALAR Solution for injection or infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MILSIA Emulsion for injection/infusion MPI, Generic Health Products Regulatory Authority (ZA)
 PROPOVEN Emulsion for injection/infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 PROVIVE Emulsion for injection MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)